Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

6.46 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192001
Revenue 227.043251.455477.706313.83776.65754.18498.285
Cost of Revenue 38.54954.005204.216129.6915.61100
Gross Profit 188.494197.45273.49184.14761.04654.18498.285
Gross Profit Ratio 0.830.7850.5730.5870.79611
Reseach & Development Expenses 424.061580.6211,052.6431,149.662159.76796.299100.476
General & Administrative Expenses 246.161385.0251,429.799862.95238.30629.48377.393
Selling & Marketing Expenses 0000000
SG&A 246.161385.0251,429.799862.95238.30629.48377.393
Other Expenses 78.02996.217.634-1.73316.1251.5740
Operating Expenses 748.2511,061.8562,482.4422,012.614198.073125.782177.869
Operating Income -559.757-864.406-2,208.952-1,828.467-137.027-71.598-234.508
Operating Income Ratio -2.465-3.438-4.624-5.826-1.788-1.321-2.386
Total Other Income Expenses Net 12.249-28.53487.553-9.65512.193-48.2370
Income Before Tax -547.508-892.94-2,121.399-1,838.122-124.834-119.8350
Income Before Tax Ratio -2.411-3.551-4.441-5.857-1.628-2.2120
Income Tax Expense -0.479-0.071-15.027-1.481.8890.0220
Net Income -547.029-892.869-2,104.929-1,830.047-126.609-119.3270
Net Income Ratio -2.409-3.551-4.406-5.831-1.652-2.2020
EPS -10.54-18.37-50.15-53.83-3.97-4.150
EPS Diluted -10.54-18.4-50.2-55.53-4-4.150
EBITDA -484.394-821.293-2,059.659-1,806.673-108.585-106.659-219.712
EBITDA Ratio -2.133-3.266-4.564-5.983-1.403-1.496-2.235